Asarina Pharma Investor Relations Material
Latest events
Q4 2023
27 Feb, 2024
Q2 2023
23 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Asarina Pharma
Access all reports
Asarina Pharma is a Swedish biopharmaceutical company focused on the development of treatments for neurological and hormonal disorders. The company is engaged in clinical research to address conditions related to hormonal imbalances, particularly those affecting the central nervous system. It develops synthetic compounds for therapeutic use in underserved medical areas. The company is headquartered in Solna, Sweden, and its shares are listed on the OMXSTO.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ASAP
Country
🇸🇪 Sweden